News Release

F647 New Drug Application (NDA) DRAFT In Review By Shanghai Food and Drug Administration

• Notice for Large Volume Exercise of the 30th Round of Stock Options
• Notice for Payment for Third-Party Allotment and the Issuance of the 30th Round of Stock Options